相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators
Samantha E. Yohn et al.
MOLECULAR PSYCHIATRY (2020)
mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia
Hoau-Yan Wang et al.
MOLECULAR PSYCHIATRY (2020)
Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity
Mario de la Fuente Revenga et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Positive modulation of mGluR5 attenuates seizures and reduces TNF-α+ macrophages and microglia in the brain in a murine model of virus-induced temporal lobe epilepsy
Tyler J. Hanak et al.
EXPERIMENTAL NEUROLOGY (2019)
Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors
Alessia Luoni et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia
Branden J. Stansley et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Targeting metabotropic glutamate receptors for the treatment of neuroinflammation
Francesco Fazio et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system
Luisa Di Menna et al.
NEUROPHARMACOLOGY (2018)
Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects
Mitul A. Mehta et al.
PSYCHOPHARMACOLOGY (2018)
Pyramidal cell regulation of interneuron survival sculpts cortical networks
Fong Kuan Wong et al.
NATURE (2018)
Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents
Paulina Cieslik et al.
PSYCHOPHARMACOLOGY (2018)
mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
Serena Notartomaso et al.
SCIENTIFIC REPORTS (2018)
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Brian J. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Expression of the K+/Cl- cotransporter, KCC2, in cerebellar Purkinje cells is regulated by group-I metabotropic glutamate receptors
Serena Notartomaso et al.
NEUROPHARMACOLOGY (2017)
Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022
Monika Wozniak et al.
NEUROPHARMACOLOGY (2017)
PARVALBUMIN NEURONS AND PERINEURONAL NETS IN THE MOUSE PREFRONTAL CORTEX
Hiroshi Ueno et al.
NEUROSCIENCE (2017)
Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk
S. M. Saini et al.
TRANSLATIONAL PSYCHIATRY (2017)
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity
Silvia Sacchi et al.
SCIENTIFIC REPORTS (2017)
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies
Dragana Bugarski-Kirola et al.
BIOLOGICAL PSYCHIATRY (2017)
Decreased free D-aspartate levels are linked to enhanced D-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients
Tommaso Nuzzo et al.
NPJ SCHIZOPHRENIA (2017)
Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia
Susana Conde-Ceide et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia
Carlo Maj et al.
CURRENT NEUROPHARMACOLOGY (2016)
Involvement of GABA(B) Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu(4) Receptor, LSP4-2022
Monika Wozniak et al.
CURRENT NEUROPHARMACOLOGY (2016)
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
M. O. Trepanier et al.
MOLECULAR PSYCHIATRY (2016)
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia
Darrick T. Balu et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Association of DISC1, BDNF, and COMT polymorphisms with exploratory eye movement of schizophrenia in a Chinese Han population
Zheng Dong et al.
PSYCHIATRIC GENETICS (2016)
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Jose L. Moreno et al.
SCIENCE SIGNALING (2016)
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Jose L. Moreno et al.
SCIENCE SIGNALING (2016)
Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia
Bruce J. Kinon et al.
BIOLOGICAL PSYCHIATRY (2015)
Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
Guillermo Gonzalez-Burgos et al.
BIOLOGICAL PSYCHIATRY (2015)
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies
Antonio Vita et al.
BIOLOGICAL PSYCHIATRY (2015)
Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders
S. A. Barnes et al.
MOLECULAR PSYCHIATRY (2015)
Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis
Giuseppe Battaglia et al.
NEUROBIOLOGY OF DISEASE (2015)
The selective mGluR5 agonist CHPG attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells
Jun-Ling Qiu et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia
Joanna M. Wieronska et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents
Jerri M. Rook et al.
NEURON (2015)
Losing the sugar coating: Potential impact of perineuronal net abnormalities on interneurons in schizophrenia
Sabina Berretta et al.
SCHIZOPHRENIA RESEARCH (2015)
Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage
Marta Motolese et al.
MOLECULAR BRAIN (2015)
The role of inflammation in schizophrenia
Norbert Mueller et al.
FRONTIERS IN NEUROSCIENCE (2015)
Chemical Modulation of Mutant mGlu1 Receptors Derived from Deleterious GRM1 Mutations Found in Schizophrenics
Hyekyung P. Cho et al.
ACS CHEMICAL BIOLOGY (2014)
mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests
Mira Lainiola et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
AnnCatherine M. Downing et al.
BMC PSYCHIATRY (2014)
Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation
Fengtian Xue et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators - Development challenges for a promising novel antipsychotic target
Sophie Parmentier-Batteur et al.
NEUROPHARMACOLOGY (2014)
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice
Francesco Fazio et al.
NEUROPHARMACOLOGY (2014)
THE GABA EXCITATORY/INHIBITORY DEVELOPMENTAL SEQUENCE: A PERSONAL JOURNEY
Y. Ben-Ari
NEUROSCIENCE (2014)
Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes
Ryuta Fujioka et al.
MOLECULAR BRAIN (2014)
Neurophysiologic and Antipsychotic Profiles of TASP0433864, a Novel Positive Allosteric Modulator of Metabotropic Glutamate 2 Receptor
Tetsuaki Hiyoshi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity
Jerri M. Rook et al.
BIOLOGICAL PSYCHIATRY (2013)
Prenatal Stress Induces Schizophrenia-Like Alterations of Serotonin 2A and Metabotropic Glutamate 2 Receptors in the Adult Offspring: Role of Maternal Immune System
Terrell Holloway et al.
JOURNAL OF NEUROSCIENCE (2013)
Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia
Francesco Errico et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
The mGlu(5) positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat
Francois Gastambide et al.
NEUROPHARMACOLOGY (2013)
The two faces of the pharmacological interaction of mGlu2 and 5-HT2A - Relevance of receptor heterocomplexes and interaction through functional brain pathways
Hannah K. Delille et al.
NEUROPHARMACOLOGY (2013)
Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
Virginia L. Stauffer et al.
SCHIZOPHRENIA RESEARCH (2013)
A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential
Cyril Goudet et al.
FASEB JOURNAL (2012)
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Mitsumasa Kurita et al.
NATURE NEUROSCIENCE (2012)
Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia
Matthew J. Fell et al.
NEUROPHARMACOLOGY (2012)
Extracellular matrix abnormalities in schizophrenia
Sabina Berretta
NEUROPHARMACOLOGY (2012)
Pharmacological Activation of Group-II Metabotropic Glutamate Receptors Corrects a Schizophrenia-Like Phenotype Induced by Prenatal Stress in Mice
Francesco Matrisciano et al.
NEUROPSYCHOPHARMACOLOGY (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
F. Fazio et al.
MOLECULAR PHARMACOLOGY (2012)
Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
Ikwunga Wonodi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs
Miguel Fribourg et al.
CELL (2011)
Placebo response in clinical trials with schizophrenia patients
Bruce J. Kinon et al.
CURRENT OPINION IN PSYCHIATRY (2011)
Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia
Jeffrey R. Bishop et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer's Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective
Filippo Caraci et al.
MOLECULAR PHARMACOLOGY (2011)
Metabotropic glutamate receptors: From the workbench to the bedside
E. Nicoletti et al.
NEUROPHARMACOLOGY (2011)
Positive allosteric modulation of metabotropic glutamate receptor 5 down-regulates fibrinogen-activated microglia providing neuronal protection
Thomas M. Piers et al.
NEUROSCIENCE LETTERS (2011)
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Korrapati V. Sathyasaikumar et al.
SCHIZOPHRENIA BULLETIN (2011)
Targeting glutamate synapses in schizophrenia
Julie R. Field et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Extracellular Matrix-Glial Abnormalities in the Amygdala and Entorhinal Cortex of Subjects Diagnosed With Schizophrenia
Harry Pantazopoulos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats
Agnieszka Nikiforuk et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
D-Aspartate activates mGlu receptors coupled to polyphosphoinositide hydrolysis in neonate rat brain slices
Gemma Molinaro et al.
NEUROSCIENCE LETTERS (2010)
Metabotropic Glutamate Receptor 5 Activation Inhibits Microglial Associated Inflammation and Neurotoxicity
Kimberly R. Byrnes et al.
GLIA (2009)
Activation of Metabotropic Glutamate Receptor 5 Modulates Microglial Reactivity and Neurotoxicity by Inhibiting NADPH Oxidase
David J. Loane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons
Giuseppe Battaglia et al.
PLOS ONE (2009)
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
B. A. Fijal et al.
PHARMACOGENOMICS JOURNAL (2009)
Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra
Vikas Kaushal et al.
JOURNAL OF NEUROSCIENCE (2008)
ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities
Feng Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP
Leah J. Sartorius et al.
NEUROPSYCHOPHARMACOLOGY (2008)
DNA sequence variants in the metabotropic glutamate receptor 3 and risk to schizophrenia: an-association study
Sibylle G. Schwab et al.
PSYCHIATRIC GENETICS (2008)
Association analysis of the metabotropic type 3 gene (GRM3) with schizophrenia
Jeffrey R. Bishop et al.
PSYCHIATRIC GENETICS (2007)
Positive allosteric modulation of metabotropic glutarnate 5 (rnGlu5) receptors reverses N-methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex
Lucas Lecourtier et al.
BIOLOGICAL PSYCHIATRY (2007)
Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia
Corrado Corti et al.
BIOLOGICAL PSYCHIATRY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection
Corrado Corti et al.
JOURNAL OF NEUROSCIENCE (2007)
Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population
N. Aoyama et al.
GENES BRAIN AND BEHAVIOR (2006)
Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment
JR Bishop et al.
SCHIZOPHRENIA RESEARCH (2005)
A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models
GG Kinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial-derived fas ligand
DL Taylor et al.
JOURNAL OF NEUROSCIENCE (2005)
No evidence for association between polymorphisms in GRM3 and schizophrenia
Nadine Norton et al.
BMC PSYCHIATRY (2005)
A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population
Q Chen et al.
SCHIZOPHRENIA RESEARCH (2005)
NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin
S Alagarsamy et al.
NEUROPHARMACOLOGY (2005)
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia
MF Egan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ca2+ activity at GABAB receptors constitutively promotes metabotropic glutamate signaling in the absence of GABA
T Tabata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Disruption of prepulse inhibition in mice lacking mGluR1
SA Brody et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents
GG Kinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia
Y Fujii et al.
PSYCHIATRIC GENETICS (2003)
Reactivation of ocular dominance plasticity in the adult visual cortex
T Pizzorusso et al.
SCIENCE (2002)
Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease
DL Taylor et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function
G Mannaioni et al.
JOURNAL OF NEUROSCIENCE (2001)
The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia
RS Devon et al.
MOLECULAR PSYCHIATRY (2001)
Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges
S Attucci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons
A Pisani et al.
NEUROSCIENCE (2001)
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
GK Aghajanian et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
